Resveratrol reduces the proinflammatory effects and lipopolysaccharide- induced expression of HMGB1 and TLR4 in RAW264.7 Cells

Cellular Physiology and Biochemistry

Volumn 33, Issue 5, 2014, Pages 1283-1292

  Yang, Ying ^a   Li, Shuping ^a   Yang, Qiao ^b   Shi, Yu ^a   Zheng, Min ^a   Liu, Yanning ^a   Chen, Feng ^a   Song, Guangzhong ^c   Xu, Hangdi ^b   Wan, Tianhong ^a   He, Jiliang ^d   Chen, Zhi ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c INSTITUTE OF MATERIA MEDICA   (China)

^d ZHEJIANG UNIVERSITY   (China)

Author keywords

High mobility group box 1; Lipopolysaccharides; Macrophages; Resveratrol; Toll like receptor 4

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; RESVERATROL; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; HMGB1 PROTEIN, MOUSE; NONSTEROID ANTIINFLAMMATORY AGENT; STILBENE DERIVATIVE; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLORIMETRY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IMMUNOFLUORESCENCE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; DRUG STRUCTURE; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; CHEMICAL STRUCTURE; DOSE RESPONSE; GENETICS; INFLAMMATION; STRUCTURE ACTIVITY RELATION;

MURINAE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HMGB1 PROTEIN; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MOLECULAR STRUCTURE; RNA, MESSENGER; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP; TOLL-LIKE RECEPTOR 4;

EID: 84899596065     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000358696     Document Type: Article

References (39)

1. Leu TH, Charoenfuprasert S, Yen CK, Fan CW, Maa MC: Lipopolysaccharide- induced c-Src expression plays a role in nitric oxide and TNFalpha secretion in macrophages. Mol Immunol 2006;43:308-316. (Pubitemid 41668840)
2. Rui Y Liu X Li N Jiang Y Chen G Cao X Wang J. PECAM-1 ligation negatively regulates TLR4 signaling in macrophages Immunol 2007 179 7344-7351.
3. Shen T, Yang WS, Yi YS, Sung GH, Rhee MH, Poo H, Kim MY, Kim KW, Kim JH, Cho JY: AP-1/IRF-3 Targeted Anti-Inflammatory Activity of Andrographolide Isolated from Andrographis paniculata. Evid Based Com plement Alternat Med 2013;210736.
4. Lee YG, Lee WM, Kim JY, Lee JY, Lee IK, Yun BS, Rhee MH, Cho JY: Src kinase-targeted anti-inflammatory activity of davallialactone from Inonotus xeranticus in li popolysaccharide-activated RAW264.7 cells. Br J Pharmacol 2008; 154:852-863. (Pubitemid 351821587)
5. Yayeh T, Jung KH, Jeong HY, Park JH, Song YB, Kwak YS, Kang HS, Cho JY, Oh JW, Kim SK, Rhee MH: K orean Red Ginseng Saponin Fraction Downregulates Proinflammatory Mediators in LPS Stimulated RAW264.7 Cells and Protects Mice against Endotoxic Shock. J Ginseng Res 2012;36:263-269.
6. Takimoto Y, Qian HY, Yoshiga i E, Okumura T, Ikeya Y, Nishizawa M: Gomisin N in the herbal drug gomishi (Schisandra chinensis) suppresses inducible nitric oxide synthase gene via C/EBPbeta and NF-kappaB in rat hepatocytes. Nitric Oxide 2013;28:4 7-56.
7. Lewis RS, Kolesnik TB, Kuang Z, D'Cruz AA, Blewitt ME, Masters SL, Low A, Willson T, Norton RS, Nicholson SE: TLR regulation of SPSB1 controls inducible nitric oxide synthase induction. J Immu nol 2011;187:3798-3805.
8. Rendon-Mitchell B, Ochani M, Li J, Han J, Wang H, Yang H, Susarla S, Czura C, Mitchell RA, Chen G, Sama AE, Tracey KJ, Wang H: IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J Immunol 2003;170:3890-3897. (Pubitemid 36361997)
9. Chen G, Li J, Ochani M, Rendon-Mitchell B, Qiang X, Susarla S, Ulloa L, Yang H, Fan S, Goyert SM, Wang P, Trac ey KJ, Sama AE, Wang H: Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14-and TNF-dependent mechanisms. J Leukoc Biol 2004;76:994-1001. (Pubitemid 39462000)
10. Lin T, Sammy F, Yang H, Thun divalappil S, Hellman J, Tracey KJ, Warren HS: Identification of hemopexin as an anti-inflammatory factor that inhibits synergy of hemoglobin with HMGB1 in sterile and infectious inflammation. J Immunol 2012;189: 017-2022.
11. Andersson U, Tracey KJ: HMGB1 is a therapeutic target for sterile inflammation and Infection. Annu Rev Immunol 2011;29:139-162.
12. Yang H, Hreggvidsdottir HS, Palmblad K, Wang H, Ochani M, Li J, Lu B, Chavan S, Rosas-Ballina M, Al-Abed Y, Akira S, Bierhaus A, Erlandsson-Harris H, Andersson U, Tracey KJ: A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and a ctivation of macrophage cytokine release. Proc Natl Acad Sci USA 2010;107:11942-11947.
13. Hu HC, Wang TY, Chen YC, Wang CC, Lin MC: RNA interference inhibits high mobility group box 1 by lipopolysaccha ride-activated murine macrophage RAW 264.7 secretion. J Surg Res 2011;168:e181-187.
14. Zhu S, Li W, Li J, Sama AE, Wang H: Caging a Beast in the Inflammation Arena: Use of Chinese Medicinal Herbs to Inhibi t a Late Mediator of Lethal Sepsis, HMGB1. Int J Clin Exp Med 2008;1:64-75.
15. Yang H, Ochani M, Li J, Qiang X, Tanovic M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, Czura CJ , Wang H, Roth J, Warren HS, Fink MP, Fenton MJ, Andersson U, Tracey KJ: Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci USA 2004;101:296-301. (Pubitemid 38084244)
16. Li W, Li J, Ashok M, Wu R, Chen D, Yang L, Yang H, Tracey KJ, Wang P, Sama AE, Wang H: A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammator y mediator, high mobility group box 1. J Immunol 2007;178:3856-3864. (Pubitemid 46417655)
17. Li W, Ashok M, Li J, Yang H, Sama AE, Wang H: A major ingredient of green tea rescues mice from lethal sepsis partly by inhibiting HMGB1. PLoS One 2007;2:e1153.
18. Youn HS, Lee JY, Fitzgerald KA, Young HA, Akira S, Hwang DH: Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: Mole cular targets are TBK1 and RIP1 in TRIF complex. J Immunol 2005;175:3339-3346. (Pubitemid 41170555)
19. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218-220. (Pubitemid 127696281)
20. Pervaiz S: Resveratrol: From grapevines to mammalian biology. FASEB J 2003;17: 975-1985.
21. Qureshi AA, Guan XQ, Reis JC, Papasian CJ, Jabre S, Morrison DC, Qureshi N: Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophag es by resveratrol, a potent proteasome inhibitor. Lipids Health Dis 2012;11:76.
22. Yang Q, Liu Y, Shi Y, Zheng M, He J, Chen Z: The role of intracellular high-mobility group box 1 in the early activation of Kupffer cells and the development of Con A-induced acute liver failure. Immunobiology 20 13;218:1284-1292.
23. Zhu F Ding H Zhu B Transcriptional profiling of Drosophila S2 cells in early response to Drosophila C virus Virol J 2013 10 210.
24. Simoes AE, Pereira DM, Amaral JD, Nunes AF, Gomes SE, Rodrigues PM, Lo AC, D'Hooge R, Steer CJ, Thibodeau SN, Borralho PM, Rodrigues CM: Efficient recovery of proteins from multiple source samples after TRIzol((R)) or TRIzol((R))LS RNA extraction and long-term storage. BMC Genomics 2013;14:181.
25. Marcant A, Denys A, Melchior A, Martinez P, Deligny A, Carpentier M, Allain F: Cyclophilin B attenuates the expression of TNF-alpha in lipopolysaccharide-stimulated macrophages through the induction of B cell lymphoma-3. J Immunol 2012;189:2023-2032.
26. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazi er A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ: HMG-1 as a late mediator of endotoxin lethality in mice. S cience 1999;285:248-251. (Pubitemid 29329996)
27. Tang D, Shi Y, Kang R, Li T, Xiao W, Wang H, Xiao X: Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J Leukoc Biol 2007;81: 741-747. (Pubitemid 46393551)
28. Liu WX, Zhu HH, Wu W, He JL, Chen Z: Inhibition effect produced by dominant negative mutant fusion protein PreS2-TLM-ScFv-HBcDN on HBV replication in vitro. J Viral Hepat 2012;19:295-300.
29. Min HJ, Ko EA, Wu J, Kim ES, Kwon MK, Kwak MS, Choi JE, Lee JE, Shin JS: Chaperone-like activity of high-mobility group box 1 protein and its role in reducing the formation of polyglutamine aggregates. J Immunol 2013;190:797-1806.
30. Xu Q, Si LY: Resveratrol role in cardiovascular and metabolic health and potential mechanisms of action.. Nutr Res 2012;32:648-658.
31. Svajger U, Jeras M: Anti-inflammatory effects of resveratrol and its potential use in therapy of immune-mediated diseases. Int Rev Immunol 2012;31:202-222.
32. Rossol M, Heine H, Meusch U, Quandt D, Klein C, Sweet MJ, Hauschildt S: LPS-induced cytokine production in human monocytes and macrophages. Crit Rev Immunol 2011;31:379-446.
33. Miller AM, Horiguchi N, Jeong WI, Radaeva S, Gao B: Molecular mechanisms of alcoholic liver disease: Innate immunity and cytokines. Alcohol Clin Exp Res 2011;35:787-793.
34. Kim S, Kim SY, Pribis JP, Lotze M, Mollen KP, Shapiro R, Loughran P, Scott MJ, Billiar TR: Signaling of high mobility group box 1 (HMGB1) through toll-like receptor 4 in macrophages requires CD14. Mol Med 2013;19:88-98.
35. Ve T, Gay NJ, Mansell A, Kobe B, Kellie S: Adaptors in toll-like receptor signaling and their potential as therapeutic targets. Curr Drug Targets 2012;13:1360-1374.
36. Bianchi ME: DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol 2007;81:1-5. (Pubitemid 46028489)
37. Evankovich J, Billiar T, Tsung A: Toll-like receptors in hepatic ischemia/reperfusion and Transplantation. Gastroenterol Res Pract 2010;537263.
38. Langefeld T, Mohamed W, Ghai R, Chakraborty T: Toll-like receptors and NOD-like receptors:domain architecture and cellular signalling. Adv Exp Med Biol 2009;653:48-57.
39. Piccinini AM, Midwood KS: DAMPening inflammation by modulating TLR signalling. Mediators Inflamm 2010/2010:672395.